We are live on ! Find out more

258 hedge funds and large institutions have $5.97B invested in DexCom in 2015 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 79 increasing their positions, 105 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more funds holding in top 10

Funds holding in top 10: 611 (+5)

55% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 29

31% more capital invested

Capital invested by funds: $4.55B → $5.97B (+$1.42B)

5% more funds holding

Funds holding: 245258 (+13)

2% less call options, than puts

Call options by funds: $30.6M | Put options by funds: $31.3M

25% less repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 105

Holders
258
Holders Change
+13
Holders Change %
+5.31%
% of All Funds
6.92%
Holding in Top 10
11
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+83.33%
% of All Funds
0.29%
New
45
Increased
79
Reduced
105
Closed
29
Calls
$30.6M
Puts
$31.3M
Net Calls
-$722K
Net Calls Change
+$9.83M

DXCM Hedge Fund Activity: Q2 2015 in Review

258 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q2 2015, worth a combined $5.97B — up 31% from $4.55B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new DXCM positions and 29 closed out — a net gain of 16 holders — while 79 added to existing stakes and 105 trimmed.

The largest buyer was Winslow Capital Management, opening a new position worth an estimated $174M. The largest seller was BlackRock Fund Advisors, cutting an estimated $90.2M.

  • 258 institutional investors held DexCom (DXCM) as of Q2 2015, up from 245 in Q1 2015.
  • Funds reported $5.97B of DexCom stock for Q2 2015, up 31% quarter-over-quarter.
  • 45 funds opened new DexCom positions in Q2 2015 and 29 closed out, a net change of +16 holders.
  • The largest DexCom buyer in Q2 2015 was Winslow Capital Management, an estimated $174M added.
  • The largest DexCom seller in Q2 2015 was BlackRock Fund Advisors, an estimated $90.2M sold.

Based on aggregated 13F filings for Q2 2015.